Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results
- 11 January 2015
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 25 (7) , 2041-2048
Abstract
To test the feasibility and accuracy of MR-guided soft tissue tumour biopsy at 3T, using the dynamic contrast-enhanced (DCE) information from staging MRI for intralesional targeting.Keywords
This publication has 35 references indexed in Scilit:
- Musculoskeletal Neoplasms: Biopsy and InterventionRadiologic Clinics of North America, 2011
- Open incisional biopsy is a safe and accurate technique for soft tissue tumoursAnz Journal of Surgery, 2010
- MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular ParametersAmerican Journal of Roentgenology, 2009
- The diagnostic value of needle biopsy for musculoskeletal lesionsInternational Orthopaedics, 2009
- Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosisRadiation Medicine, 2008
- Magnetic Resonance Imaging-Guided Percutaneous Biopsy of Musculoskeletal LesionsJournal of Bone and Joint Surgery, 2007
- Grading in soft tissue tumors: principles and problemsSkeletal Radiology, 2001
- Clinicopathologic Re-Evaluation of 100 Malignant Fibrous Histiocytomas: Prognostic Relevance of SubclassificationJournal of Clinical Oncology, 2001
- Bone and soft tissue tumors: the role of contrast agents for MR imagingEuropean Journal of Radiology, 2000
- Diagnosis of soft tissue tumours by Tru-Cut® biopsyBritish Journal of Surgery, 1990